Thurston Springer Miller Herd & Titak’s Teladoc Health TDOC Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36K	Hold	278	–	–	﹤0.01%	1079
2026 Q1	$1.51K	Hold	278	–	–	﹤0.01%	1208
2025 Q4	$1.95K	Buy	278 +200	+256%	+$1.57K	﹤0.01%	1218
2025 Q3	$602	Sell	78 -315	-80%	-$2.46K	﹤0.01%	518
2025 Q2	$3.42K	Buy	393 +15	+4%	+$109	﹤0.01%	1345
2025 Q1	$3.01K	Buy	378 +100	+36%	+$1.01K	﹤0.01%	1377
2024 Q4	$2.53K	Sell	278 -200	-42%	-$1.93K	﹤0.01%	1103
2024 Q3	$4.39K	Hold	478	–	–	﹤0.01%	1223
2024 Q2	$4.67K	Buy	+478	New	+$5.83K	﹤0.01%	1195

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's TDOC Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Teladoc Health (TDOC) position steady in Q2 2026 at 278 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Thurston Springer Miller Herd & Titak first reported a position in TDOC in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.67K in Q2 2024. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Thurston Springer Miller Herd & Titak held 278 shares of Teladoc Health worth $2.36K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1079 holding.
Thurston Springer Miller Herd & Titak first reported a position in Teladoc Health in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's Teladoc Health position peaked at $4.67K in Q2 2024.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.